Larvol Delta - Acumen-Pharmaceuticals-to-Present-Topline-Results-from-FirstinHuman-Phase-1-Study-of-ACU193-for-Early-Alzheimers-Disease-During-Featured-Research-Session-at-the-Alzheimers-Association-International-Conference-AAIC-2023

ACU193 - Acumen Pharma

https://www.globenewswire.com/news-release/2023/06/13/2686991/0/en/Acumen-Pharmaceuticals-to-Present-Topline-Results-from-First-in-Human-Phase-1-Study-of-ACU193-for-Early-Alzheimer-s-Disease-During-Featured-Research-Session-at-the-Alzheimer-s-Asso.html

Jun 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next